Analyses of the The Cancer Genome Atlas (TCGA) dataset has linked the presence of elevated mutations or candidate MHC class-I neoantigens with increased levels of perforin and granzyme-A mRNA transcripts, suggesting a link between the level of genomic alterations and effective anti-tumor immune responses23. Here, PRF1 is linked to neoplasm.